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Plants and plant derived products exert chemopreventive effects on various cancer cell lines by the induction of cell death
mechanisms. The effects of root acetone extract of Rubus fairholmianus (RFRA) on the proliferation of human colorectal cancer
(Caco-2) cells have been investigated in this study. The extract led to a dose dependent decrease in both viability and proliferation
and increased cytotoxicity using trypan blue exclusion, adenosine 5󸀠-triphosphate (ATP), and lactate dehydrogenase (LDH) assay.
The morphological features of the treated cells were supportive for the antiproliferative activity. The Annexin V/propidium iodide
staining indicated that R. fairholmianus induced toxic effects in Caco-2 cells and the percentages of the early and late apoptotic
population significantly increased when compared with control cells. Also we studied the apoptosis inducing ability of the extract
by analysing caspase 3/7 activity and the induction of cell death via the effector caspases was confirmed; the activity increased
in treated cells compared with control. Thus the present findings highlight that the R. fairholmianus root acetone extract exhibits
antiproliferative activity on Caco-2 cells by the induction of apoptosis via caspase dependent pathway.
1. Introduction
Cancer is a dreaded disease characterized by uncontrolled
growth and spread of abnormal cells. The high mortality rate
amongst cancer patients is an indication of limited efficiency
of current therapies [1]. Identifying the mechanism of plant
derived anticancer agents provides helpful information in
cancer therapy. Natural products have been used for the
treatment of various diseases for centuries. Evidences have
shown that active principle compounds from plants may
serve as potent chemotherapeutic agents with less toxicity
to normal tissues and at low cost [2]. Plants have a long
history of use in cancer therapy and it is significant that over
60% of currently used anticancer agents are from natural
sources and around 80% of people in rural areas depend
on plant products for their primary healthcare needs [3].
They are associated with induction of apoptosis, cell cycle
arrest, inhibition of various signal transducers, and signaling
pathways [4, 5]. Thus, it is important to screen the crude
extract of plants or isolated compounds for their apoptotic
potentials. The use of alternative medicine is increasing and
many pharmaceutical industries are interested in developing
plant derived medicinal compounds [6]. The increasing cost
of conventional treatments and the lack of effective drugs
encouraged people to depend more on folk medicine.
Berries such as Rubus, Fragaria, Sorbus, Ribes, and Vac-
cinum are common inWestern diets.These soft fruits are rich
in bioactive phytochemicals including several classes of phe-
nolic compounds [7]. Berries from Rubus genus (cloudberry,
raspberry, and blackberry) primarily contain ellagitannins
and anthocyanins [8]. The evidence supports that anticancer
properties of berries are due to the scavenging free radicals,
induction of enzymes involved in xenobiotics metabolism,
regulation of gene expression, alteration of cellular signalling,
and induction of apoptosis [9, 10]. The search for better
cytotoxic agents continues to be important in the discovery
of modern anticancer drugs. Several bioactive compounds
of plants act as lead compounds in drug discovery due to
their structural diversity, bioactivities and the therapeutic
potential of these compounds can be improved by molecular
modifications.
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Cancers that start in the cells lining inside of the colon and
rectum are called colorectal cancers (CRC). CRC are the third
most predominant cancers worldwide and are the fourth
most common cause of cancer mortality with approximately
9.4% of global cancer cases irrespective of gender. The rate of
incidence of CRC has been observed more in Australia/New
Zealand, Europe, USA, and UK. African and Asian coun-
tries have a far lower rate of incidence [11]. According
to epidemiological studies the major risk factors of CRC
incidence include obesity, smoking, alcohol consumption,
increasing age, family history, and dietary factors [12, 13].
Several flavonoid-rich foods could display relevant cancer-
preventive effects. Thus, the isolation of potential chemopre-
ventive agents from plants has contributed to breakthrough
in anticancer studies [14]. Carcinoma colon (Caco-2) cell
line originates from human colonic adenocarcinoma and
shows similarities to small intestinal enterocytes [15]. These
cells develop typical morphology of enterocytes with distinct
apical and basolateral membrane domains, microvillus, and
tight junctions [16]. The cells can be grown on uncoated
polycarbonate filters to obtain well-differentiatedmonolayers
[17].
The genus Rubus is very diverse, with over 750 species in
12 subgenera, and is found on all continents except Antarctica
[18]. Due to useful ethnomedicinal and pharmacological
properties, Rubus species have been used in folk medicine
[19]. R. fairholmianus (R. moluccanus L.) leaf extract has been
administrated to reduce headache [20]; these leaves possess
insecticidal properties; fruits are edible with stimulating
effect [21]. On the basis of the previously reported, anti-
inflammatory, wound healing [22], and in silico anticancer
properties [23], we have selected this plant for this study.
Even though this plant has immense ethnomedicinal value,
a survey of literature revealed that the in vitro anticancer
potential of this plant has not yet been evaluated. Keeping this
in view, the aim of the present study was to investigate the
in vitro anticancer potential and track the possible cell death
mechanisms of R. fairholmianus root acetone extract, to put
forward a scope to develop an effective drug.
2. Materials and Methods
2.1. Plant Material Collection, Identification, and Extraction.
The fresh plant parts of R. fairholmianus were collected from
Shola forest of Marayoor, Idukki District, Kerala, India, dur-
ing September 2010. Plant parts were identified and authen-
ticated (voucher specimen number BSI/SRC/5/23/2010-11/
Tech.1657) by Botanical Survey of India, Southern Cir-
cle, Coimbatore, Tamil Nadu, India. The shade dried and
powdered roots were extracted in Soxhlet apparatus using
acetone. The extractability of phenolic compounds in the
polar solvent like acetone was found to be high. Moreover,
acetone extract has shown better pharmacological effects in
many previous studies inRubus.The extractwas concentrated
to dryness under reduced pressure in a rotary evaporator
to yield dried root acetone extract. The dried extract then
dissolved in 0.5% DMSO and was used for further analysis.
The preliminary screening of leaves, stem, and root for total
phenolics, tannin, flavonoids, and antioxidant properties
showed that root had the maximum activity [24].
2.2. Cell Culture. The commercially obtained colorectal
cancer cells (Caco-2 ATCC HTB-37) were used. Caco-2 cells
were cultured in Dulbecco’s modified Eagle’s media (DMEM,
Sigma-Aldrich, D 6429) with 1.2 g/L sodium carbonate,
supplemented with 10% foetal bovine serum (FBS, Gibco,
306.00301), 10mM nonessential amino acids (Gibco, 11140),
0.5mMsodiumpyruvate (Gibco, 11360), 2.5mML-glutamine
(Gibco, 25030), 1% antibiotic (penicillin-streptomycin,
Gibco, 15140), and 1% antifungal (amphotericin-B, Gibco,
104813) agents. Culture was maintained at 37∘C with 5% CO
2
and 85% humidity. Once cells reached 80–90% confluence,
they were harvested and seeded at a concentration of 5 ×
104 in 3mL culture media into sterile culture dishes, with a
diameter of 3.4 cm. Cells were allowed to attach overnight.
2.3. Cellular Morphology-Inverted Microscopy. The effect of
the plant extract on cellmorphologywas determined using an
inverted light microscope (Wirsam, Olympus CKX41) after
24 h of incubationwith different concentrations (5, 10, 20, and
40 𝜇g/mL) of RFRA and 0.5% DMSO. Once digital images
were recorded, cells were trypsinized using 1mL/25 cm2 of
TrypLE Express (Invitrogen, 12605-028) and resuspended in
Hank’s Balanced Salt Solution (HBSS) to perform further
assays.
2.4. Cell Viability-Trypan Blue Dye Exclusion Assay. The
trypan blue dye exclusion assay (Sigma-Aldrich T8154) is a
quantitative method to determine the percentage viability.
Here, the viable cells with an intact cellular membrane do not
take up the blue dye andmaintain a clear appearance whereas
the damaged nonviable cells take up dye and stained blue as
their membrane damages.
The cell suspension was carefully mixed with 0.4% trypan
blue reagent in 1 : 9 ratio and the mixture was transferred to a
Neubauer hemocytometer to determine the number of viable
and nonviable cells. Cells were counted by using automated
cell counter (Countess Automated Cell Counter, Invitrogen).
2.5. Cellular Proliferation-Adenosine Triphosphate (ATP)
Luminescent Assay. The CellTiter-Glo1 luminescent assay
(Promega, G7571, Anatech Analytical Technology, Bellville,
South Africa) is a homogeneous method for determination
of cellular proliferation and quantification of ATP present in
metabolically active cells.
Fifty microliters of reconstituted reagent was added to an
equal volume of cell suspension and then mixed in a shaker
for 2 minutes to induce cell lysis. This was then incubated
at room temperature for 10 minutes in dark to stabilize the
luminescent signal.The luminescent signalwas read using the
1420 Multilabel Counter Victor3 (Perkin-Elmer, Separation
Scientific).
2.6. Cytotoxicity-Lactate Dehydrogenase (LDH) Assay. The
membrane integrity was assessed by estimating the amount of
LDHpresent in the culturemedia.The cytosolic enzymeLDH
will be released due to membrane damage. The CytoTox96
X assay (Anatech, Promega G 400) was used to measure
the released LDH. Fifty microliters of reconstituted reagent
was added to an equal volume of cell culture medium and
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incubated in the dark at room temperature for 30min. The
colorimetric compound was measured spectrophotometri-
cally at 490 nm (Perkin-Elmer, VICTOR3).
2.7. Cell Death Analysis-Annexin V/PI Staining. TheAnnexin
V fluorescein isothiocyanate (FITC) apoptosis detection kit
(Becton Dickinson, 556570, Scientific Group, Randburg,
South Africa) was used to detect apoptotic cells by fluo-
rescence activated cell sorting (FACS). In apoptotic cells,
the membrane phospholipid phosphatidyl serine, which is
normally found in the internal portion of the cell membrane,
becomes translocated to the outer leaflet of the plasma
membrane, thereby exposing phosphatidyl serine to the
external environment. Annexin V is a calcium dependent
phospholipid binding protein that has an affinity for phos-
phatidylserine and is useful in identifying apoptotic cells.
Cells were resuspended in 1x binding buffer at a con-
centration of 1 × 106/mL. One hundred microliters of the
cell suspension was transferred to a 5mL falcon tube and
stained with 5mL of FITC Annexin and 5mL of propidium
iodide (PI). The cells were gently vortexed and incubated
for 15min at room temperature and protected from light.
After the addition of 400mL of 1x binding buffer to each
tube the samples were run in FACSAria flow cytometer
(Becton Dickinson) by running 20000 events and analysed
with CellQuest Software (BD Bioscience).
2.8. Quantification of Caspase 3/7 Activity. The effector cas-
pases 3 and 7 play central role in apoptotic process. All steps
were performed according to the manufacturer’s procedure.
Tumour necrotic factor-alpha (TNF-𝛼) is able to initiate
apoptosis by activating caspase 8, which in turn activates
caspases 3 and 7. Activity of caspases 3/7 in apoptosis was
determined with the Caspase-Glo 3/7 luminescent assay
(Whitehead Scientific, Bracken fell, South Africa, Promega
G8091).
Fifty microliters of treated cells was seeded in a 96-
well luminescent plate (Scientific Group Adcock Ingram,
Midrand, South Africa, BD354651). Fifty microliters of
Caspase-Glo 3/7 reagent is added and the plate was then
incubated at room temperature for 3 h. Luminescence was
read using the Victor3 (Perkin-Elmer, Separation Scientific,
Johannesburg, South Africa).
2.9. Statistical Analysis. A colorectal cancer cell line between
15 and 20 passages was used. Each set of experiments was
repeated six times (𝑛 = 6) whereas each assay was performed
in duplicates, with the results being averaged. Untreated cells
were included throughout the course of study and all treated
samples were compared to those cells by means of one-way
ANOVA to determine the statistical difference. Statistical
analysis was performed using SigmaPlot version 12.0 and the
mean, standard deviation and standard error were obtained.
Statistical significances between untreated control cells and
treated cells are shown in the graphs as𝑃 < 0.05 (∗),𝑃 < 0.01
(∗∗), and 𝑃 < 0.001 (∗ ∗ ∗). Significant differences were
considered at the 95th percentile.
3. Results and Discussion
There are many reports available on the increased cancer cell
death via induction of apoptosis or by many other means
using different plant extracts or the natural compounds.Most
of the chemopreventive agents used currently are nonspecific
and kill both cancerous and normal cells causing various
side effects. But the use of plant derived agents reduces this
risk and it is more specific to the cancer cells. In this study
the antiproliferative activity of R. fairholmianus root acetone
extract on Caco-2 cells was examined.
The morphological changes of Caco-2 treated cells with
various concentrations of RFRA extracts were incubated
for 24 h and compared with the untreated cells shown in
Figure 1. Compared to control cells after the incubation
period, morphology of RFRA treated Caco-2 cells signifi-
cantly changed. The extract treated cells appeared less uni-
formwith the loss ofmembrane integrity, although still intact
at lower concentrations (5 and 10 𝜇g/mL). Whereas at 20
and 40 𝜇g/mL concentrations the RFRA treated cells showed
remarkable difference with the control group.The significant
changes such as loss of intact membrane, karyopyknosis, cell
detachment from the plate, and change of morphological
features were evident when compared to untreated cells.
The most identifiable morphological features of apoptosis
were observed by inverted light microscopy in the RFRA
treated cells. The treated cells appeared like cells undergoing
apoptosis with prominent features such as detaching from
the culture plate, cytoplasmic condensation, cell shrinkage
and condensation and aggregation of the nuclear chromatin,
and loss of contact with neighbouring cells [25]. However the
untreated cells appeared normal and were confluent.
The cell viability of the Caco-2 cells was assessed by
trypan bluemethod. Trypan blue is an energy-dependent dye
exclusion viability testing method; the dye is being excluded
from live cells. As trypan blue is a weak acid, its affinity
is increased for basic proteins; nuclei uptake is generally
higher due to the presence of histones, yielding marked blue
intensity, whereas the cytoplasm remains faintly stained [26].
Thismethod helped to determine the percentage of viable and
dead cells in the RFRA treated Caco-2 cells. The results are
presented in Table 1. There was a dose dependent decrease in
viability of the treated cells. The control cells showed 83.83%
viability, whereas RFRA treated cells showed 71.33, 61.50,
52.50, and 41.00% for 5, 10, 20, and 40 𝜇g/mL, respectively.
The decrease in percentage of viability becomes significant
with all different concentrations of RFRA (𝑃 < 0.01 for
5 𝜇g/mL and 𝑃 < 0.001 for 10, 20, and 40 𝜇g/mL, resp.). The
net loss of viability at the higher concentrations in trypan
blue assay indicated the cytotoxic effect of RFRA towards
Caco-2 cells. No other studies have been published previously
revealing the influence of RFRA on viability of Caco-2 cell
lines. Similar results were also observed in R. occidentalis
(black raspberry) extracts, they suppressed the proliferation
of colon (HT-29), prostate (LNCaP), oral (KB, CAL-27),
and breast (MCF-7) tumour cell lines [27, 28], and the cell
viability decreased in a dose dependent manner. The extracts
of some Rubus species such as R. jamaicensis, R. rosifolius,
R. racemosus, R. acuminatus, and R. idaeus also exhibited
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Figure 1: Morphological features of Caco-2 cells after 24 h treatment with RFRA (R. fairholmianus root acetone) extract. There were no
significant visible differences in both control and 0.5% DMSO treated cells (a and b). The RFRA extract treated cells (c, d, e, and f) after 24 h
showed loss of intact membrane, loss of contact with neighbouring cells, condensed and detached from the culture plate.
Table 1: Trypan blue viability and LDH cytotoxicity assays.
Groups Viability percentage LDH cytotoxicity
Control 83.83 ± 1.28 0.3490 ± 0.02
0.5% DMSO 82.83 ± 0.98 0.3677 ± 0.02
5 𝜇g/mL RFRA 71.33 ± 2.75∗∗ 0.4580 ± 0.07∗∗
10 𝜇g/mL RFRA 61.50 ± 2.54∗∗∗ 0.5328 ± 0.06∗∗∗
20 𝜇g/mL RFRA 52.50 ± 3.34∗∗∗ 0.5943 ± 0.07∗∗∗
40 𝜇g/mL RFRA 41.00 ± 3.59∗∗∗ 0.6508 ± 0.06∗∗∗
Values are mean ± standard error of six independent assays performed in
duplicates. The significant differences between treated and controls groups
are shown as ∗∗∗𝑃 < 0.001 and ∗∗𝑃 < 0.01. (RFRA: R. fairholmianus root
acetone extract; LDH: lactate dehydrogenase; DMSO: dimethyl sulfoxide.)
great potential to inhibit cancer cell growth, inhibiting colon,
breast, lung, and gastric human tumour cells [29].
The LDH leakage assay is a simple reliable and fast
cytotoxicity assay based on the measurement of lactate
dehydrogenase activity in the extracellular medium. LDH,
a cytoplasmic enzyme released when the cell membrane
damages, is assessed in cell culture supernatants [30]. The
cell membrane damage of Caco-2 cells after the treatment
with RFRA extract was measured by the release of LDH by
followingCytoTox961 assay.The control cells and cells treated
with DMSO showed lesser LDH release when compared
to cells exposed to plant extracts. The RFRA treatments
provoked a higher release of LDH activity than the control
nontreated cells. There was a significant (𝑃 < 0.01 with
5 𝜇g/mL and 𝑃 < 0.001 with 10, 20, and 40 𝜇g/mL of RFRA)
dose dependent increase in the LDH release observed at
increasing concentrations of RFRA (Table 1).The intracellular
LDH release to the medium is a measure of irreversible cell
death due to cell membrane damage, whereas Xia et al. [31]
reported the direct involvement of LDH upregulation and
subsequent induction of apoptosis.
Cellular ATP content was assessed to determine the level
of metabolic activity of cells. The CellTiter-Glo1 luminescent
assay was performed to evaluate the proliferating potential of
cells. ATP is a marker for cell viability and proliferation and
present in all metabolically active cells. Some reports suggest
that ATP can induce cell proliferation, differentiation, and
apoptosis, mediating different pathophysiological functions
depending on the target cell [32]. The energetic level in
Caco-2 cells remained higher, which was evident from the
increased ATP level in control and DMSO treated cells.
Exposure of Caco-2 cells to the RFRA caused a reduction
in the intracellular ATP pool (Figure 2). The Caco-2 cells
after RFRA treatments showed significant changes in cellular
proliferation as compared to control cells. All the four tested
concentrations of RFRA exhibited significant changes in
cellular proliferation. The cells incubated with increasing
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Figure 2:TheATP luminescent cell proliferation assay was used to determine Caco-2 cell proliferation. Control and 0.5% treated cells showed
an increase in ATP level, whereas a dose dependent significant (𝑃 < 0.001) decrease in ATP level was observed in RFRA (R. fairholmianus
root acetone) extract treated experimental groups (5, 10, 20, and 40𝜇g/mL concentrations of RFRA).
concentrations (5, 10, 20, and 40 𝜇g/mL) of RFRA resulted
in a dose dependent highly significant decrease (𝑃 < 0.001)
in cellular proliferation compared with control Caco-2 cells.
The actively dividing cells produce ATP, the main production
occurs in mitochondria, and the depletion in ATP correlated
with the decreased cell proliferation rate [33]. The ATP
quantity drops soon after cell death and results in a loss
of luminescence in assay [34]. RFRA extracts decreased the
cell proliferation and was manifested from the decline of
luminescence.
The Annexin V FITC apoptosis detection kit was used
to distinguish the apoptotic and necrotic cells using flow
cytometry. To further understand whether the decrease in
cell viability observed was due to apoptosis, we examined
the behaviour of cells after treatment using Annexin V/PI
staining. The percentage of apoptotic cells increased with
the increase in concentration of RFRA. The control and
0.5% DMSO treated cells showed no significant changes
in percentage of cell population, most of the cells lined
in the live cells range during flow cytometry analysis. The
RFRA treated cells showed an increase in the percentages of
early and late apoptotic cells. The nonapoptotic or necrotic
cells concentration in the treated extracts was found to be
very low compared with the control group. Figure 3 shows
the results of Annexin V-PI staining after the treatment
with RFRA extract to Caco-2 cells. In the control groups,
the Annexin V+/PI+ population was less (3.3%) and was
compared with experimental groups. The RFRA treated
groups such as 5, 10, 20, and 40 𝜇g/mL showed 24.7, 31.2,
39.6, and 55.8 percentages of late apoptotic cells population.
When Caco-2 cells were treated with the RFRA, the early
(Annexin V+/PI−) and late (Annexin V+/PI+) apoptotic
population increased concurrently and induced a decrease in
the viable cell (Annexin V−/PI−) and necrotic or dead cell
(Annexin V−/P+) population. Although both late apoptotic
and necrotic cells are AnnexinV and PI positive, the presence
of these cells with early apoptotic cells suggests that such
dead cells resulted from the apoptosis rather than necrosis
[35]. These findings confirmed that apoptosis may be the
possible mechanism by which the RFRA triggers cell death
in Caco-2 cells.The absence or significantly low percentage of
cell population in quadrant (Annexin V−/PI+) of the RFRA
treated Caco-2 cells ruled out necrosis [36].
To evaluate the inhibition of cell growth, release of LDH,
the increase in early and late apoptotic cell population in
response to RFRA treatments was due to caspase dependent
pathway; the caspase 3/7 activity was measured. Caspases
are a family of cysteine-aspartic proteases known as the vital
mediators of apoptotic signalling [37]. Caspases 3 and 7 are
well established as the major executioner (effector) caspases
and their activation eventually leads to cell death [38]. The
measure of caspase 3/7 activity in the cells is a direct mean
for the determination of caspase dependent apoptosis. There
was a significant dose dependent increase in the caspase 3/7
activities (𝑃 < 0.01 for 5 𝜇g/mL and 𝑃 < 0.001 for 10, 20,
and 40 𝜇g/mL) observed in treated cells with the increase in
concentrations of RFRA (Figure 4). Low levels of caspase 3/7
activity were detected in the control and 0.5% DMSO treated
cells, which was presumably due to the small amount of
apoptotic cells present in the growing cell population. Among
the effector caspases, caspases 3 and 7 play a vital role in
the execution phase of intrinsic and extrinsic pathways of
apoptosis by cleavingmany crucial cellular proteins [39].This
cleavage facilitates disassembly of cell, which is evident from
themorphological changes, such as cell shrinkage, chromatin
condensation, membrane blebbing, and DNA fragmentation
[40]. These morphological changes were also observed from
the RFRA treated cells and strongly suggested the caspase
mediated apoptotic cell death in Caco-2 cells. Kim and
coworkers [41] reported the caspase 3/7 activity and apoptosis
inducing ability of R. coreanum,a closely related species of R.
fairholmianus on HT-29 human colon cancer cells.
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68.1 ± 2.32 22.3 ± 0.57
27.1 ± 0.5965.4 ± 2.213.6 ± 0.81
0.5 ± 0.38
∗∗∗ 24.5 ± 1.22∗∗ 50.3 ± 0.52 ∗∗∗ 24.7 ± 1.03 ∗∗
31.2 ± 1.54 ∗∗∗
39.6 ± 1.98 ∗∗∗
55.8 ± 2.23 ∗∗∗
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53.6 ± 1.09 ∗∗∗
39.5 ± 2.00 ∗∗
7.4 ± 1.03∗∗∗
6.6 ± 1.89∗∗∗
4.2 ± 0.78∗∗∗
1.1 ± 0.49
∗∗
0.2 ± 0.12
∗∗∗
0.4 ± 0.28
∗∗∗
Values are mean ± standard error of three independent assays performed in duplicates. The significant differences between treated and controls groups are shown as∗∗∗P < 0.001 and
∗∗
P < 0.01 (RFRA: R. fairholmianus root acetone extract).
Figure 3: Annexin V FITC/PI staining used to assess the mode of cell death. RFRA (R. fairholmianus root acetone) treated Caco-2 cells
showed an increased percentage of apoptotic population after 24 h incubation. The population of early and late apoptotic cells in control
group found to be lower (22.3 and 3.3%) compared with experimental groups; the attached table shows the statistical data of flow cytometric
analysis.
Many plant extracts and isolated compounds have been
reported for the antiproliferative activities and some of them
showed their phototoxic effects on different cancer cell lines
by inducing the cell death. Hypericin, a second generation
photosensitizer isolated from Hypericum perforatum, has
been shown to act as a potent light-activated photosensitizer
in numerous in vitro and in vivo systems [42]. The further
research is warranted to find out the photosensitising ability
of R. fairholmianus since it has great antiproliferative activ-
ities. The irradiation of the extracts and isolated bioactive
compounds may be helpful in killing cancer cells via genera-
tion of reactive oxygen species.
4. Conclusions
The present study demonstrated a dose dependent antitumor
effect of R. fairholmianus root acetone extract on human
colorectal cancer cell (Caco-2). A significant decrease in the
cell viability, proliferation, and increase in cytotoxicity and
caspase 3/7 activity were observed after the treatment with
RFRA. The Annexin V/PI staining supports the apoptosis
induced cell death. Moreover, the morphological alterations
in the Caco-2 cells exposed to RFRA extract were suggestive
for the apoptotic activities and this is described for the
first time. The data demonstrate that this plant exhibits
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Figure 4: Caspase 3/7 activity determined as a function of caspase
dependent apoptosis in Caco-2 cells after the treatment with RFRA
(R. fairholmianus root acetone) extract. There was a significant dose
dependent increase in caspase 3/7 activity after RFRA treatments
(𝑃 < 0.01 and 𝑃 < 0.001) compared to control and 0.5% DMSO
treated cells.
an inhibitory effect and seems to indicate the caspase 3/7
mediated apoptotic cell death triggered in Caco-2 cells.
The outcome of this study recommends that the substantial
antiproliferative activity of R. fairholmianus may be due to
the caspase dependent apoptosis and the compounds of this
extractmay have promising use as a cancer chemotherapeutic
agent.
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